STATENS SERUM INSTITUT
- Country
- Denmark
- Type
- Beneficiary
- Website
- www.ssi.dk
- Grants received
- 55
Funding record
- 55 grants on record
- €34,332,258.59 awarded in total
- 2008–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Seventh Framework Programme
- Horizon Europe Framework Programme
- Horizon 2020 Framework Programme
- European Research Council
23 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- Department of Health
- ISTITUTO SUPERIORE DI SANITA
- RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- ACADEMISCH ZIEKENHUIS LEIDEN
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- INSTITUT PASTEUR
Calls from this organisation
No published calls from this organisation.
Grants received
- Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness PLUS
- European Partnership Animal health and Welfare
- “CLEAR”: Cell Envelope Antibacterials
- Pandemic Information to Support Rapid Response
- Integrating Multi-Disciplinary Expertise in a Learning and Adaptive European Pandemic Preparedness System
- NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN
- Intranasal, rapid-acting vaccine for all seasonal and pandemic influenza viruses
- Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity
- Respiratory Host-Pathogen Interaction
- Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness
- Integrated Services for Infectious Disease Outbreak Research
- Preparing for RSV Immunisation and Surveillance in Europe
- SUPporting high quality evaluation of COVID-19 convalescent Plasma thrOughoutT Europe
- DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE
- Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic preparedness, public health and socio-economic benefits
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.